...

Trusted Pharmaceutical Manufacturer From India To Mali

In Mali, Actiza Pharmaceutical Pvt. Ltd. is at the forefront of enhancing healthcare outcomes by providing high-quality pharmaceutical products. Our cutting-edge manufacturing facilities and stringent quality control processes guarantee that each medication meets global standards of safety and effectiveness. We offer an extensive range of essential treatments to cater to the healthcare needs of the Malian population. Through strategic collaborations with local healthcare providers and stakeholders, we improve access to necessary medications and support Mali’s healthcare infrastructure. Our commitment to excellence and innovation ensures that we remain a reliable partner in the nation’s healthcare sector. We are dedicated to promoting health equity and affordability, aiming to make a positive impact on public health and the well-being of Mali’s citizens. At Actiza, our mission is to drive significant improvements in healthcare delivery and outcomes, contributing to a healthier and more prosperous Mali.

View More

Our facilities Accredited & Complied

With WHO-GMP standards, We offer seamless service from the Plant registration to Development/Registration, and Commercialisation of the products globally

Pharmexcil
ISO CERTIFIED
WHO CERTIFIED
Goverment recognized Star Export House
Food and Drugs Control Administration

40+

Exporting Countries

12+

Years Of Experience

500+

Clients Globally

2000+

Product Lines

550+

Ready Dossiers

Have a query, send us a quick enquiry

    * We will contact you shortly over an Email or Phone.

    Actiza Pharmaceutical Pvt Ltd – Strengthening India-Mali Pharmaceutical Ties

    Actiza Pharmaceutical Pvt. Ltd. stands out in India’s pharmaceutical sector. The firm is renowned for its high-quality products and global shipping. Its excellent reputation comes from its manufacturing skills and success in international trade. Actiza Pharmaceutical Pvt. Ltd drugs are in high demand worldwide. Their influence now extends well beyond Mali.

    Its 242 products now reach patients in 40+ countries, with Africa as its latest conquest. Mali and India strengthen ties through medicine. This alliance brings affordable, high-quality drugs to Mali. India’s pharmaceutical expertise helps meet Mali’s healthcare needs. Actiza Pharmaceutical Pvt. Ltd enhances this relationship by providing excellent goods and services. It improves Mali’s healthcare and access to medicine.

    Overview of the strong bilateral relationship between India and Mali

    In 2024, India’s pharmaceutical exports to Mali soared to $30.12 million. This milestone showcases the thriving medical trade between the two nations. The pharmaceutical partnership thrives as demand increases.

    It highlights India’s key role in delivering needed medications. This year, India’s exports to Mali were $130.45 million. Medicines made up a large part of this. This alliance improves Mali’s healthcare and strengthens ties between the two nations.

    Pharmaceutical Market Overview in Mali

    Mali’s pharmaceutical sector grows as demand for medicine increases. Experts forecast growth through 2024 due to increased medicine production and access. India is the leading supplier of most imported medications. 2018 the nation’s first pharmaceutical factory opened, followed by a second. However, both plants are in financial trouble.

    It raises doubts about the new industry’s future. Counterfeit drugs and illegal imports plague the market. They account for 55-60% of sales. This issue threatens drug businesses and consumer safety. Despite these obstacles, solid networks and local alliances offer hope.

    Mali’s Healthcare Landscape: A Growing Need for Quality Medicines

    Mali needs better medications, which is changing its healthcare. Limited local production has created a gap. So, India now supplies most drugs. However, this reliance reveals flaws in manufacturing. It risks Mali’s independence and supply. Local factories struggle with operations and funds.

    They also face issues with counterfeit drugs and illegal imports. Mali’s future in healthcare depends on improving drug quality and access. Solving these problems will boost the pharmaceutical sector and public health.

    India’s Role in Mali’s Pharmaceutical Sector

    Indian medications are common in Mali’s clinics and pharmacies. India’s $29.65 million in 2023 pharma exports are a vital lifeline. India’s drug supply strengthens Mali’s healthcare. This country production capacity is low. So, it must import medical supplies from India.

    India’s aid bolsters this country healthcare, supplying quality drugs to a growing market. Counterfeits and illegal imports make up 55-60% of sales. But, this partnership improves medical access. The collaboration tackles challenges in our nation pharma sector.

    Ensuring Safety and Efficacy: Our Commitment to Mali

    Actiza Pharmaceutical Pvt. Ltd. is dedicated to drug safety and efficacy for patients in This Country. We ensure our drugs meet high standards before they are sold. Our WHO, GMP, and ISO certifications prove our commitment to quality. These ensure our medicines meet global standards. We follow guidelines and conduct checks to maintain this quality.

    Our main goal is to meet Mali’s healthcare needs. We offer reliable and efficient drug solutions. Our approach is innovative and aligned with international standards. We aim to meet national needs with innovation and safety.

    Statistical Data on Pharmaceutical Trade Between India and Mali

    The pharmaceutical trade between Mali and India is expanding. Here is a complete analysis of the critical data:

    Export and Import Statistics

    This Country received $50 million worth of pharmaceutical exports from India in 2023. This is a portion of India’s broader pharmaceutical exports to Africa, which total $3.5 billion.

    This Country has received pharmaceutical shipments from India at a 15% yearly growth rate.

    Market Share

    Twenty per cent of the world’s pharmaceutical market is in India. With 20% and 50% shares, respectively, Indian pharmaceutical businesses substantially contribute to the worldwide supply of vaccines and generic pharmaceuticals.

    Growth Trends

    The pharmaceutical industry in India is growing at a 10-12% yearly growth rate. This country is seeing an increase in exports, consistent with a robust 15% annual growth rate.

    Manufacturing Pharmaceutical Products for Mali

    India plays a crucial role in supplying pharmaceutical products to this country. Here’s how we ensure high-quality manufacturing and meet local needs:

    • Capsule
    • Injection
    • Creams / Ointment
    • Drops
    • Gel
    • Suspension/syrup
    • Nasal Drops/Sprays
    • Infusion
    • Inhaler
    • Lotion

    Overview of Manufacturing Process

    Raw Material Selection: We rigorously select and test our top-notch ingredients. This ensures our products are safe and potent.

    Manufacturing: Our medicines are made in facilities that meet GMP standards. These facilities provide about 30% of Guinea’s drugs.

    Quality Assurance: We follow strict international quality standards. This ensures our products are top-notch. We test every item to meet these standards.

    Packaging: Our packaging meets global standards. Products are durable and comply with regulations.

    Compliance and Export: Exports need certification from the U.S. FDA and WHO. They must also meet this country standards.

    Quality Assurance

    Our quality control meets international standards. We test every batch before shipping. This ensures we comply with the, WHO, and GMP. Thus, we guarantee each product’s safety and effectiveness.

    Customization for Local Needs

    We customize our products for this country healthcare. Our designs meet local rules and address specific issues. Country relies on our vital medical supply chain. We deliver 60% of the nation’s vital medicines. This ensures millions of millions access to effective treatments.

    Corporate Social Responsibility: Contributing to Mali’s Health and Well-being

    Our corporate social responsibility programs aim to boost health in this country. We offer necessary medications and support local health efforts. Our goals are to improve health education and access. We are working with local groups to address this country healthcare challenges.

    We aim to improve healthcare nationwide. We want to boost medical infrastructure and citizens’ quality of life. Together, we strive to enhance medical services and improve lives.

    Conclusion – A Future of Health and Prosperity for India and Mali

    In 2024, this country and India’s pharmaceutical partnership is booming. India’s exports to our nation rose by $50 million, showing a strong economic link. Actiza Pharmaceutical Pvt. Ltd. is key, providing top-quality, certified drugs to this country.

    This collaboration enhances healthcare access and paves the way for future growth. It faces challenges like counterfeit drugs and low local production. Yet, it continues to move forward.

    The partnership tackles these issues, fostering innovation and improving medical care. It promises better health and wealth for both nations.

    Request A Call Back